[Post-transcriptional regulation mechanism and antiviral strategy of hepatitis B virus RNA]. [PDF]
Li DY +6 more
europepmc +1 more source
[New progress on diagnosis and treatment for indeterminate-phase chronic hepatitis B virus-infected patients]. [PDF]
Liu JC, Wu C, Li J.
europepmc +1 more source
[Research progress on the effect of hepatitis B virus DNA integration on antiviral therapy]. [PDF]
Zhao J, Chen XY, Zheng SJ.
europepmc +1 more source
[A case of hepatitis B virus-related hepatocellular carcinoma with low-level viremia achieved seronegative conversion with entecavir combined with tenofovir amibufenamide]. [PDF]
Ren WG +5 more
europepmc +1 more source
[Correlation between hepatitis B virus infection and adverse pregnancy outcomes-a systematic review and meta-analysis]. [PDF]
Cai WQ +5 more
europepmc +1 more source
[Epidemiological analysis of the current prevalence of hepatitis B virus infection among pregnant and postpartum women in China from 2021 to 2023]. [PDF]
Huang DX +6 more
europepmc +1 more source
[Strategies for hepatitis B virus-infected patients in the immune-tolerant phase: complete therapy at the last mile]. [PDF]
Ding Y, Sheng QJ, Dou XG.
europepmc +1 more source
[Research progress on the role of hepatitis B virus DNA integration in chronic hepatitis B]. [PDF]
Chen YM, Liu J, Zhu CW, Zhu L.
europepmc +1 more source
[Inhibitory effect of small-molecule compound AM679 targeting elongation-factor binding protein 2 on hepatitis B virus in vitro]. [PDF]
Fang HJ +5 more
europepmc +1 more source
[Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma]. [PDF]
Yang JL +5 more
europepmc +1 more source

